06/11/2025
4:59 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
4:04 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
5:39 PM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:55 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
7:26 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:22 PM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:26 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:27 PM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:28 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:31 PM | Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:17 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VIR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. |
06/02/2025
6:19 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
6:20 PM | Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:29 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2025
7:23 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
12:02 PM | BlackRock, Inc. (Filed by)
Vir Biotechnology (Subject)
| Form SCHEDULE 13G/A | |
04/17/2025
8:27 AM | Vir Biotechnology (Filer)
| Form ARS | |
04/17/2025
7:40 AM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/17/2025
7:33 AM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/04/2025
3:23 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
6:50 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
11:39 AM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:01 AM | Vir Biotechnology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:23 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
2:43 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:44 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:34 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:36 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:37 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:39 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:41 PM | O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:56 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:57 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:57 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:38 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:40 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
6:11 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:50 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
5:41 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:49 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:51 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
"I'm risking my reputation on this" (Ad) Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented.
And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots…
What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book. Claim your FREE copy of Crypto Revolution now. |
01/08/2025
7:03 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:22 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
6:50 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
12:36 PM | O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:20 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:51 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
3:20 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:26 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
11:29 AM | STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
| Form SC 13G/A | |
10/02/2024
11:09 AM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
11:07 AM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/10/2024
3:28 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
7:10 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:29 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:43 PM | Vir Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2024
3:40 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
